enprofylline has been researched along with Arterial Diseases, Carotid in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monteiro, EC | 1 |
| Ribeiro, JA | 1 |
1 other study available for enprofylline and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Inhibition by 1,3-dipropyl-8(p-sulfophenyl)xanthine of the respiratory stimulation induced by common carotid occlusion in rats.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Hemodynamics; Rats; Rats, | 1989 |